Fibromyalgia: Impact of Self-Knowledge on Well-Being
Fibromyalgia: The Impact of Self-Knowledge on the Well-Being of People With Fibromyalgia
1 other identifier
interventional
16
1 country
1
Brief Summary
The goal of this observational study is to evaluate the impact of self-knowledge training on the well-being of individuals with fibromyalgia. The main questions it aims to answer are: Does self-knowledge training improve participants' perceived quality of life? Does self-knowledge training influence the way participants manage their fibromyalgia symptoms? Participants will: Take part in a structured self-knowledge intervention based on the Enneagram framework. Complete validated questionnaires before and after the intervention to assess their well-being. Provide qualitative feedback on their experience with the training. This study will help understand whether self-awareness strategies can be integrated into non-pharmacological approaches for fibromyalgia management.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 18, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 24, 2024
CompletedFirst Submitted
Initial submission to the registry
March 24, 2025
CompletedFirst Posted
Study publicly available on registry
April 6, 2025
CompletedApril 6, 2025
March 1, 2025
1 month
March 24, 2025
April 2, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Quality of Life (EQ-5D-3L)
The EQ-5D-3L is a generic instrument for assessing health-related quality of life (HRQoL), comprising five dimensions: Mobility, Self-Care, Usual Activities, Pain/Discomfort, and Anxiety/Depression. Each dimension is rated on a 3-level scale (1 = no problems, 2 = moderate problems, 3 = severe problems). The responses generate a health index, where higher scores indicate worse quality of life.
Baseline and after completion of the 10-week intervention
Perceived Quality of Life (EQ-VAS)
The EQ-VAS is a visual analogue scale measuring self-perceived health status. Participants rate their health on a 0-100 scale (0 = worst imaginable health state, 100 = best imaginable health state). Higher scores indicate better perceived quality of life.
Baseline and after completion of the 10-week intervention
Mental Health - Depression, Anxiety, and Stress (DASS-21)
The DASS-21 is a 21-item questionnaire assessing symptoms of depression, anxiety, and stress. It includes three subscales (7 items each), rated on a 0-3 scale (0 = does not apply at all, 3 = applies very much or most of the time). Higher scores indicate greater severity of symptoms.
Baseline and after completion of the 10-week intervention
Secondary Outcomes (2)
Psychological Flexibility (Psy-Flex Scale)
Baseline and after completion of the 10-week intervention
Self-Reflection and Insight (SRIS Scale)
Baseline and after completion of the 10-week intervention
Study Arms (2)
Self-Knowledge Training Group
EXPERIMENTALParticipants in this group will undergo a self-knowledge training program based on the Enneagram framework. The program consists of 2 sessions, focusing on self-awareness, emotional regulation, and personal growth.
Control Group
NO INTERVENTIONParticipants in this group will not receive any self-knowledge training during the study period. They will continue with their usual care and will be assessed at the same time points as the intervention group.
Interventions
The intervention consists of a self-knowledge training program based on the Enneagram framework. Participants attend 7 sessions, focusing on self-awareness, emotional regulation, and personal development. The sessions include theoretical explanations, guided self-reflection exercises, and group discussions to help participants better understand their personality patterns and how these influence their perception of pain and well-being.
Eligibility Criteria
You may qualify if:
- Diagnosis of fibromyalgia
- Age ≥ 18 years
- Ability to understand and provide informed consent
You may not qualify if:
- Cognitive impairment that prevents comprehension of the intervention
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Faculdade de Medicina da Universidade de Coimbra
Coimbra, 3000-548, Portugal
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- ANA ISABEL RIBEIRO CRUZ
Study Record Dates
First Submitted
March 24, 2025
First Posted
April 6, 2025
Study Start
June 18, 2024
Primary Completion
July 31, 2024
Study Completion
October 24, 2024
Last Updated
April 6, 2025
Record last verified: 2025-03